Price To Earnings Ratio 63.14 | Sector PE 70.55 |
PB Ratio 20.85 | Sector PB 8.91 |
EPS 34.83 | Dividend Yield 1.65 |
Today's Volume 27.138 K | 5 Day Avg. Volume 59.601 K |
PEG Ratio -18.63 | Market Cap. ₹ 38,560.00 Cr. |
GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The company's field of activity is the production, distribution and trade of medicines. It produces drugs used in the pharmaceutical industry, such as antibiotics, endocrine products, essential vitamins; opium derivatives; sulfa drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and plant alkaloids and chemically pure sugar. It offers a variety of prescription drugs, vaccines and consumer health products. Its drug portfolio includes Adartrel, Bactroban, Combodart and Duodart. Its vaccine portfolio includes Ambirix, Cervarix, Fendrix and Havrix. The company's products include betamethasone, clavulanate potassium with amoxicillin, and pneumococcal polysaccharide and conjugate vaccine. Its oral care products include Sensodyne, parodontax and Polident. Its manufacturing unit is located in Nashik.